Are biosimilars delivering the goods in the EU?

March 10, 2009
Manufacturing and Production, Research and Development biosimilars

In January, leading pharmaceutical experts attended the 2009 Forum Institute seminar on biosimilars, and the challenges involved in their successful …

Merck unveils $41 billion takeover of Schering-Plough

March 9, 2009
Sales and Marketing MA, Merck

Merck is to acquire Schering-Plough for $41.1 billion, creating a new industry giant to challenge Pfizer in terms of its …

GSW unveils new European offering

March 6, 2009
Medical Communications GSW

GSW Worldwide, one of the biggest global healthcare advertising agencies has announced the launch of a new pan-European offering.GSW is …

P&G sponsors ulcerative colitis DVD

March 6, 2009
Sales and Marketing GI, digi

Procter & Gamble Pharmaceuticals is sponsoring and distributing a new educational DVD that aims to explain ulcerative colitis (UC) to …

UCB plans new Belgian biomanufacturing plant

March 6, 2009
Manufacturing and Production UCB

Belgian biopharmaceutical company UCB has earmarked euros 65 million for the construction of its first biologics manufacturing plant in Braine-l'Alleud. …

UK’s Stem Cell Sciences acquired by US company

March 5, 2009
Research and Development Stem cells

US company StemCells Inc is to expand its capabilities in the field with the purchase of UK based Stem Cell …

NICE rejects Tyverb despite price offer

March 5, 2009
Research and Development NICE, Tyverb

NICE has rejected GSK's breast cancer drug Tyverb, despite an offer from the company to cut the cost of treatment. …

Pfizer expands product deal with Indian generic company

March 5, 2009
Sales and Marketing Asia, India, Pfizer, generics

Pfizer has linked up with Indian drug manufacturer Aurobindo Pharma to expand its portfolio of generic medicines in the US …

Obama makes ‘downpayment’ on US healthcare reform

March 5, 2009
Research and Development US, healthcare

President Barack Obama has reiterated his aim of bringing universal healthcare to the US and has put a $76.8 billion …

UK worst hit in Europe by pharma industry cutbacks

March 5, 2009
Business Services, Sales and Marketing Jobs

The pharmaceutical industry's prolonged and painful period of restructuring looks set to continue, and UK pharma is thought to be …

Symbicort gains COPD indication

March 4, 2009
Research and Development Symbicort

AstraZeneca's respiratory drug Symbicort can be used to help US patients with chronic obstructive pulmonary disease (COPD). The FDA has …

Bayer boosted by Schering integration

March 4, 2009
Sales and Marketing Bayer

Profits at Bayer's healthcare division rose by 10% to 4.1 billion euros last year as it increasingly felt the benefits …

FDA puts block on Ranbaxy products

March 4, 2009
Manufacturing and Production Ranbaxy

India’s Ranbaxy Laboratories has been dealt another blow by the FDA after the agency suspended regulatory review of any products …

First-in-class cancer treatment Vidaza launched

March 3, 2009
Research and Development Vidaza

Vidaza, an innovative new treatment for a number of hard-to-treat blood cancers, has been launched in the UK by Celgene. …

Roche and Bayer Schering ‘named and shamed’ for Code breaches

March 3, 2009
Sales and Marketing ABPI, Code of Practice

Roche and Bayer Schering Pharma have been publically reprimanded for bringing discredit upon the UK pharma industry.Bayer fell foul of …

Darzi plans for a faster NICE process

March 3, 2009
NHS

Health minister Lord Darzi has unveiled proposals that would see the NICE appraisal process speeded up considerably. NICE has been …

Grabbing the Gorilla: Making adverts sell

March 3, 2009
Medical Communications, Sales and Marketing advertising, branding

Awareness, persuasion and emotional appeal are all important factors in effective advertising. The key is to draw attention to the …

Contract manufacturing could profit from downturn

March 2, 2009
Manufacturing and Production Kalorama

The market for contract manufacturing of prescription drugs exceeded $30 billion last year, a 10% increase that is being fuelled …

Chinese move marks ‘globalisation’ of Bayer Schering R&D

March 2, 2009
Research and Development Asia, Bayer, China

Bayer Schering Pharma's plan to build a 100 million-euro R&D centre in Beijing marks the company's first major foray into …

The Gateway to Local Adoption Series

Latest content